ALLO - Allogene Therapeutics GAAP EPS of -$0.38 beats by $0.03
2024-05-13 16:09:59 ET
More on Allogene Therapeutics
- Allogene Therapeutics: 2024 Platform Vision Sings Mid-Term Upside
- Allogene Therapeutics, Inc. (ALLO) Q4 2023 Earnings Call Transcript
- Allogene Therapeutics Q1 2024 Earnings Preview
- Allogene Therapeutics GAAP EPS of -$0.51 misses by $0.06
- Seeking Alpha’s Quant Rating on Allogene Therapeutics